Antiphospholipid (APL)-positive

Clinical trials for Antiphospholipid (APL)-positive explained in plain language.

Never miss a new study

Get alerted when new Antiphospholipid (APL)-positive trials appear

Sign up with your email to follow new studies for Antiphospholipid (APL)-positive, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Could a transplant drug tame stubborn low platelets in antiphospholipid syndrome?

Disease control Recruiting now

This trial tests whether sirolimus (rapamycin), an immune-suppressing drug, can safely raise platelet counts in people with antiphospholipid antibodies and persistent low platelets. Participants are randomly assigned to receive sirolimus or a placebo for six months, and those who…

Matched conditions: ANTIPHOSPHOLIPID (APL)-POSITIVE

Phase 4 • Sponsor: Peking University First Hospital • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

Antiphospholipid (APL)-positive

Get alerted when new Antiphospholipid (APL)-positive trials appear

Could a transplant drug tame stubborn low platelets in antiphospholipid syndrome?